Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2014-05-05 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20140505 - Acquisition of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition of own shares" and details a specific transaction where UCB SA/NV repurchased 1,315,638 of its own shares OTC. It explicitly mentions the number of shares held after the transaction and references Royal Decree executing the Companies Code, indicating a regulatory disclosure regarding share capital management. This directly aligns with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase reports.
2014-05-05 English
20140505 - Acquisition d'actions.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition d'actions propres" (Acquisition of own shares) and details a specific transaction where UCB SA sold and repurchased its own shares ('racheté') from a subsidiary on specific dates (April 28, May 2, May 5, 2014). This activity directly relates to the company managing its own stock holdings, which aligns precisely with the definition of 'Transaction in Own Shares'. The code for this is POS. The document is a formal announcement ('information réglementée') detailing the transaction, not just a general regulatory filing (RNS) or a report announcement (RPA). The length (5327 chars) is substantial enough to be the primary announcement itself.
2014-05-05 French
20140505 - Transacties in eigen aandelen.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Inkoop van eigen aandelen" (Purchase of own shares) and details a specific transaction where UCB NV bought back 1,315,638 of its own shares from a subsidiary on April 28, 2014, settling on May 5, 2014. It explicitly mentions the number of shares held post-transaction and references the company's corporate governance charter. This activity—the company buying back or selling its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2014-05-05 Dutch
UCB 3 month interim report 2014 ENG.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'UCB Interim Report for the first three months of 2014'. It provides detailed financial performance data, including revenue, net sales by product, and regional breakdowns for the first quarter. It also includes management commentary on business trends and pipeline updates. Since it contains substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2014
2014-04-24 English
UCB 3 month interim report 2014 FR.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial update from UCB for the first three months of 2014. It contains detailed financial tables, revenue breakdowns by product and region, and management commentary on performance. It is not a full annual report (10-K) nor a mere announcement of a report (RPA), as it provides substantive financial data and analysis for an interim period. Therefore, it is classified as an Interim/Quarterly Report. Q1 2014
2014-04-24 French
UCB 3 month interim report 2014 NL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial update from UCB for the first three months of 2014. It contains detailed financial tables, revenue breakdowns by product and region, and management commentary on performance. It is not a full annual report (10-K) nor a mere announcement of a report (RPA), as it provides substantive financial data and analysis for an interim period. Therefore, it is classified as an Interim/Quarterly Report. Q1 2014
2014-04-24 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.